Methods for accelerating wound healing by administration of...

Details Methods for accelerating wound healing by administration of... Methods for accelerating wound healing by administration of...

2006-02-07

2009-12-29

Landsman, Robert (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S351000

Reexamination Certificate

active

07638484

ABSTRACT:
Methods for inducing or accelerating a healing process of a damaged skin or skin wounds are described. The methods include administering to the skin cells colonizing the damaged skin or skin wound a therapeutically effective amount of an adipokine, an adipocyte or preadipocyte modulator, adipocytes, preadipocytes, or stem cells, or transforming the skin cells colonizing the damaged skin or skin wound such as to express and secrete an adipokine, thereby inducing or accelerating the healing process of the damaged skin or skin wound.

REFERENCES:
patent: 4673649 (1987-06-01), Boyce et al.
patent: 4833257 (1989-05-01), Pettit et al.
patent: 4940660 (1990-07-01), Hirai
patent: 5145679 (1992-09-01), Hinson
patent: 5444041 (1995-08-01), Owen et al.
patent: 5461030 (1995-10-01), Lindenbaum
patent: 5591709 (1997-01-01), Lindenbaum
patent: 5723119 (1998-03-01), Schwarz et al.
patent: 5770228 (1998-06-01), Edwards et al.
patent: 5869037 (1999-02-01), Crystal et al.
patent: 5942487 (1999-08-01), Ogawa et al.
patent: 5981606 (1999-11-01), Martin
patent: 6028118 (2000-02-01), Dupont et al.
patent: 6096288 (2000-08-01), Roth
patent: 6319907 (2001-11-01), Ferguson
patent: 6403656 (2002-06-01), Rivier
patent: 6485721 (2002-11-01), Yoshida et al.
patent: 6489306 (2002-12-01), Mohapatra et al.
patent: 6541447 (2003-04-01), Dawson
patent: 6582713 (2003-06-01), Newell et al.
patent: 6737241 (2004-05-01), Nolan
patent: 6841472 (2005-01-01), Mayuzumi
patent: 7074408 (2006-07-01), Fanslow et al.
patent: 7261881 (2007-08-01), Sierra-Honigmann
patent: 2001/0036955 (2001-11-01), Gerritsen et al.
patent: 2002/0119914 (2002-08-01), Zhu et al.
patent: 2003/0144180 (2003-07-01), Tennenbaum et al.
patent: 2003/0147855 (2003-08-01), Zolotukhin et al.
patent: 2004/0175384 (2004-09-01), Mohapatra et al.
patent: 2005/0054608 (2005-03-01), Linge et al.
patent: 2006/0177443 (2006-08-01), Fanslow et al.
patent: 2008/0182780 (2008-07-01), Linge et al.
patent: 0 561 330 (1993-09-01), None
patent: 0 679 402 (1995-02-01), None
patent: 0 280 460 (1998-08-01), None
patent: 2 369 572 (2002-06-01), None
patent: 2 115 410 (1998-07-01), None
patent: WO 85/05036 (1985-11-01), None
patent: WO 89/10129 (1989-11-01), None
patent: WO 90/11071 (1990-10-01), None
patent: WO 92/18147 (1992-10-01), None
patent: WO 93/04691 (1993-03-01), None
patent: WO 93/25660 (1993-12-01), None
patent: WO 96/09810 (1996-04-01), None
patent: WO 96/20724 (1996-07-01), None
patent: WO 96/23522 (1996-08-01), None
patent: WO 99/18920 (1999-04-01), None
patent: WO 99/35283 (1999-07-01), None
patent: WO 99/53943 (1999-10-01), None
patent: WO 00/30628 (2000-06-01), None
patent: WO 01/76650 (2001-10-01), None
patent: WO 02/17980 (2002-03-01), None
patent: WO 02/43751 (2002-06-01), None
patent: WO 02/009639 (2002-07-01), None
patent: WO 02/072092 (2002-09-01), None
patent: WO 02/087576 (2002-11-01), None
patent: WO 02/094877 (2002-11-01), None
patent: WO 2005/007072 (2005-01-01), None
patent: WO 2007/075911 (2007-07-01), None
U.S. Appl. No. 09/169,801, filed Aug. 1, 2000, Roth.
Rangwala and Lazar, Adipogenic Transcriptional Regulation, Annu. Rev. Nutr. 2000, 20, 535-559.
Michalik et al., Impaired skin wound healing in perioxisome proliferator-activated receptor (PPAR) and PPAR mutant mice, J. Cell Biol. 2001, 154, 799-814.
Frank, et al. “Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair”,J. Clin. Investigation, vol. 106, No. 4 (2000), pp. 501-509.
Traverso, et al. “Immunological evidence for increased oxidative stress in diabetic rats”,Diabetologia(1998) 41: 265-170.
Al, et al. “The experimental study of bone marrow mesenchymal stem cells on the repair of skin wound combined with local radiation injury”,Zhonhghua Yi Xue Za Zhi, 82(23), (2002), pp. 1632-1636; Pubmed Abstract PMID 12667374.
Alessenko, et al. “Selective changes in protein kinase C isoenzymes in rat liver nuclei during liver regeneration”,Biochem. Biophys, Commun., 182, (1992), pp. 1333-1339.
Andre, et al. “Protein kinases C-gamma and -delta are involved in insulin-like growth factor I-Induced migration of colonic epithelial cells”,Gastroent. 116(1) (1999), pp. 64-77.
Bajou, et al. “Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization”,Nat. Med., 4 (1998), pp. 923-928.
Bandyopadhyay, et al. “Effects of transiently expressed atypical (ζ, Λ), conventional (α, β) and novel (δ, ε) [. . ]”,Biochem. J., 337 (1999), pp. 461-470.
Benes, et al. “The C2 domain of PKC δ is a phosphotyrosine binding domain”,Cell, 121 (2005), pp. 271-280.
Bitar, et al. “Insulin and glucocorticoid-dependent suppression of the IGF-I system I diabetic wounds”,Surgery, 127(6) (2000), pp. 687-695.
Braiman, et al. “Tyrosine phosphorylation pf specific protein kinase C izoenzymes participates in insulin stimulation of glucose transport in primary cultures of rat skeletal muscle”,Diaetes, 48(10) (1999), pp. 1922-1929.
Braiman, et al. “Protein Kinase Cδ Mediates Insulin-Induced Glucose Transport in Primary Cultures of Rat Skeletal Muscle”,Endocrin., 13(12), pp. 2002-2012, 2000.
Chida, et al. “The η isoform of protein kinase C is localized on rough endoplasmic reticulum”,Mol. Cell Biol. 14 (1994), pp. 3782-3790.
Denning, et al. “Specific protein kinase C isozymes mediate the induction of keratinocyte differentiation markers by calcium”,Cell Growth Differ., 6 (1995), pp. 149-157.
Dlugosz and Yuspa “Coordinate changes in gene expression which mark the spinous to granular call transition in epidermis are regulated by protein kinase C”,J. Cell. Biol., 120 (1993), pp. 217-225.
Ferber, et al. “Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates [. .]”,Nature Med. 6(5) (2000) pp. 568-572.
Formisano, et al. “In NIH-3T3 fibroblasts, insulin receptor interaction with specific protein kinase C isoforms controls receptor intracellular routing”,J. Biol, Chem., 273 (1998), pp. 12197-13202.
Gcshwendt “Protein kinase Cδ”,Eur. J. Biochem., 259 (1999), pp. 555-564.
Hengge, et al. “Epidermis as target for in vivo gene-therapy”,J. Invest. Dermatol. 105(3) (1995) p. 448.
Hofmann “The potential for isoenzyme-selective modulation of protein kinase C”,The FASEB J., 11 (1997), pp. 649-669.
Jeschke, et al. “IGF-I gene transfer in thermally injured rats”,Gene Ther., 6(6) (1999), pp. 1015-1020.
Jeschke, et al. “Effect of multiple gene transfer of insulinlike growth factor I complementary DNA gene constructs in rats after thermal injury”,Arch. Surg., 134(10) (1999), pp. 1137-1141.
Lindenbaum, et al. “Serum-free culture medium induces acceleration of wound healing in guinea-pigs”,Burns, 21(2) (1995), pp. 110-115.
MacFarlane, et al. “Glucose stimulates translocation of the homeodomain of transcription factor PDX1 from the cytoplasm to the nucleus of pancreatic bet-cells”,J. Biol. Chem., 274(2), (1999), pp. 1001-1016.
Madibally, et al. “Influence of insulin therapy on burn wound healing in rats”,J. Surg. Res., 109 (2003), pp. 92-100.
Mischak, et al. “Phorbol ester- induced myeloid differentiation is mediated by protein kinase C-α and -δ and not by protein kinase C-βII, -ε, -Ε, and -η”,J. Biol. Chem., 268 (1993), pp. 20110-20115.
Mischak, et al. “Overexpression of Protein Kinase C-δ and -ε in NIH 3T3 Cells Induces Opposite Effects [..]”,J. Biol. Chem., 268(9), (1993), pp. 6090-6096.
Mooney , et al. “Tumor necrosis factor and wound healing”,Annals of Surgery, 211 (2), (1990) pp. 124-129.
Ohba, et al. “Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction [..]”,Mol. Cel. Biol., 18(9)(1998), pp. 519

Affiliated with

Also associated with

Rating

Methods for accelerating wound healing by administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for accelerating wound healing by administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for accelerating wound healing by administration of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4144788